Krystal Biotech Income Statement (2016-2026) | KRYS

Income Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
8.56M42.14M45.25M70.30M83.84M91.14M88.18M96.04M97.80M107.11M116.40M
Cost of Revenue (Quarter)
0.22M2.87M2.42M6.01M6.68M4.95M5.03M7.17M4.26M6.59M6.32M
Gross Profit (Quarter)
8.33M39.27M42.83M64.29M77.16M86.19M83.16M88.88M93.54M100.51M110.08M
Operating items
Research & Development (Quarter)
6.59M6.08M9.01M9.31M10.89M11.52M10.74M12.29M12.14M10.63M11.37M10.96M15.58M13.51M13.53M14.26M14.41M14.59M14.79M15.33M
Selling, General & Administrative (Quarter)
9.80M9.57M12.87M15.91M17.86M19.93M24.03M24.04M25.90M23.70M24.65M26.06M27.63M28.67M31.29M32.65M35.16M37.58M41.45M41.01M
Restructuring Costs (Quarter)
25.00M12.50M12.50M37.50M37.50M37.50M12.50M
Other Operating Expenses (Quarter)
-12.50M100.00M-22.58M-18.99M5.03M7.17M4.26M6.59M6.32M
Operating Expenses (Quarter)
16.39M15.65M21.88M50.22M28.75M31.45M34.77M48.82M38.05M34.55M38.90M51.93M61.72M61.37M49.76M51.93M56.73M56.43M62.84M62.67M
Operating Income (Quarter)
-16.39M-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.25M-6.68M8.57M22.47M41.38M36.25M39.31M41.37M44.27M53.69M
EBIT (Quarter)
-16.39M-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.25M-6.68M8.57M22.47M41.38M36.25M39.31M41.37M44.27M53.69M
Non-operating items
Interest & Investment Income (Quarter)
-0.02M0.01M-0.15M-1.03M-0.35M0.07M0.75M0.57M-0.08M-0.15M1.09M-0.88M-0.25M1.84M-1.15M0.34M-0.16M0.66M-0.20M-1.58M
Non Operating Income (Quarter)
6.74M7.41M7.62M7.48M7.30M7.24M7.34M7.47M6.59M6.86M7.75M
Net income details
EBT (Quarter)
-39.26M-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M10.66M0.93M16.05M29.77M48.61M43.60M46.77M47.97M51.13M61.44M
Tax Provisions (Quarter)
1.97M0.48M2.60M3.13M7.86M8.40M-31.40M-0.26M5.50M
Profit After Tax (Quarter)
-16.36M-15.59M-21.95M-49.97M-28.11M-29.78M-32.05M-45.30M-33.21M80.60M8.35M0.93M15.57M29.33M45.48M36.31M38.33M79.36M51.40M55.93M
Income from Continuing Operations (Quarter)
-39.26M-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M
Consolidated Net Income (Quarter)
-39.26M-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M
Income towards Parent Company (Quarter)
-39.26M-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M
Net Income towards Common Stockholders (Quarter)
-39.26M-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M
Additional items
EPS (Basic) (Quarter)
-1.77-1.13-0.99-3.25-2.25-2.68-1.33-4.45-1.252.880.320.030.540.951.591.241.332.741.781.91
EPS (Diluted) (Quarter)
-1.77-1.13-0.99-3.25-2.25-2.68-1.33-4.45-1.252.790.310.030.530.911.531.201.292.661.721.83
Shares Outstanding (Quarter)
22.20M22.21M22.20M25.11M25.55M25.62M25.49M25.71M26.66M28.04M27.15M28.30M28.60M28.72M28.59M28.82M28.91M28.95M28.94M29.29M
Shares Outstanding (Diluted) (Quarter)
22.20M22.21M22.20M25.11M25.55M25.62M25.49M25.71M26.66M28.89M27.75M29.29M29.64M29.90M29.74M29.87M29.75M29.83M29.95M30.51M
EBITDA (Quarter)
-16.39M-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.25M-6.68M8.57M22.47M41.38M36.25M39.31M41.37M44.27M53.69M
Interest Expenses (Quarter)
22.84M9.46M30.36M28.34M37.21M66.07M169.12M133.65M150.41M236.28M219.58M209.85M156.40M198.81M117.14M180.42M298.66M286.11M
Tax Rate (Quarter)
18.44%2.97%8.73%6.44%18.04%17.96%-65.46%-0.51%8.95%